| Experimental mouse models for hepatocellular carcinoma research F Heindryckx, I Colle, H Van Vlierberghe International journal of experimental pathology 90 (4), 367-386, 2009 | 452 | 2009 |
| Clinical manifestations of hepatoma: a review of 6 years' experience at a cancer hospital DC Ihde, P Sherlock, SJ Winawer, JG Fortner The American Journal of Medicine 56 (1), 83-91, 1974 | 227 | 1974 |
| Hepatitis B virus molecular biology and pathogenesis RJ Lamontagne, S Bagga, MJ Bouchard Hepatoma research 2, 163, 2016 | 213 | 2016 |
| Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation EM Wu, LL Wong, BY Hernandez, JF Ji, W Jia, SA Kwee, S Kalathil Hepatoma research 4, 2018 | 135 | 2018 |
| Animal models as a tool in hepatocellular carcinoma research: A Review NP Santos, AA Colaco, PA Oliveira Tumor Biology 39 (3), 1010428317695923, 2017 | 124 | 2017 |
| Oxidative stress and hepatocarcinogenesis Y Fu, FL Chung Hepatoma research 4, 2018 | 67 | 2018 |
| Trends in hepatocellular carcinoma research from 2008 to 2017: a bibliometric analysis Y Miao, Y Zhang, L Yin PeerJ 6, e5477, 2018 | 64 | 2018 |
| Detection of urine DNA markers for monitoring recurrent hepatocellular carcinoma HW Hann, S Jain, G Park, JD Steffen, W Song, YH Su Hepatoma research 3, 105, 2017 | 57 | 2017 |
| Radiofrequency, microwave, and laser ablation of liver tumors: time to move toward a tailored ablation technique? P Tombesi, FD Vece, S Sartori Hepatoma Research 1, 52-57, 2015 | 52 | 2015 |
| Role of early growth response 1 in liver metabolism and liver cancer N Magee, Y Zhang Hepatoma research 3, 268, 2017 | 45 | 2017 |
| Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma S Raza, S Rajak, B Anjum, RA Sinha Hepatoma research 5, 2019 | 44 | 2019 |
| Comprehensive review of H epatitis BV irus‐associated hepatocellular carcinoma research through text mining and big data analytics WY Lee, M Bachtiar, CCS Choo, CG Lee Biological Reviews 94 (2), 353-367, 2019 | 43 | 2019 |
| Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease J Zhou, M Tripathi, RA Sinha, BK Singh, PM Yen Hepatoma research 7, 2021 | 39 | 2021 |
| Advances in genomic hepatocellular carcinoma research W Huang, AJ Skanderup, CG Lee Gigascience 7 (12), giy135, 2018 | 39 | 2018 |
| Understanding the inflammation-cancer transformation in the development of primary liver cancer HJ Chen, MH Hu, FG Xu, HJ Xu, JJ She, HP Xia Hepatoma Res 4 (7), 29, 2018 | 38 | 2018 |
| Trout hepatoma research conference papers JE Halver US Department of the Interior, Fish and Wildlife Service, 1967 | 38 | 1967 |
| New and old biomarkers of hepatocellular carcinoma G Zacharakis, A Aleid, KK Aldossari Hepatoma Res 4 (10), 65, 2018 | 36 | 2018 |
| Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries S Yapali, N Tozun Hepatoma Res 4 (6), 24, 2018 | 35 | 2018 |
| The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer N Méndez-Sánchez, A Valencia-Rodríguez, A Vera-Barajas, L Abenavoli, ... Hepatoma research 6, 2020 | 34 | 2020 |
| Epidemiology and aetiology of hepatocellular carcinoma in Sub-Saharan Africa D Mak, A Kramvis Hepatoma Res 7 (39), 10.20517, 2021 | 31 | 2021 |
